26 SEPT
2014
and save
Leading life science investors, analysts and advisors confirmed to speak include:
Steven Yatomi-Clarke Director, Corporate Finance Patersons Securities
Jason Coloma Global Head of Venture & Innovation Roche, Switzerland
Wen Cao Principal of Shanghai Office NTD Patent & Trademark Agency, China
Dr Samantha Du Chairman & CEO, Zai Laboratory; Venture Partner, Sequoia Capital, China
Barry Palte Executive Deputy Chairman Bluemount Capital, Australia
Dr Richard M Soll Senior Vice President, International Discovery Service Unit WuXi AppTec, China
Knowledge Partner:
Lanyard Sponsor:
Supporting Partner:
• Well designed program, to allow for the right balance of keynote speakers, panel discussions, and company presentations • Additional biopartnering meeting sessions
Reasons to Attend: Dr Dan Zhang CEO Fountain Medical, China
Peter Soelberg Managing Director – Australasia Novo Nordisk, Australia
Networking Sponsor:
Silver Sponsor:
• Hear the pipeline of at least 30 Australian Biotech companies, as well as 5-10 international companies • Take part in fruitful discussions through the biopartnering system • Listen to expert panellists and keynote speakers discuss the trends and opportunities in biotech currently
• Be a part of one of the most important events on the life sciences calendar To register, www.AusBiotechInvest.com/registration or contact Beacon Events at +852 2219 0111 or email to
[email protected]
Registration
• Liaise and network with investors, pharma representatives, and biotech companies
2013 Attended Investors
State Host Sponsor:
James Posnett Manager Listings Business Development ASX, Australia
• Additional spaces made available to biotech companies to present their pipelines
Conference Day Two
Scott Power Senior Analyst Healthcare & Biotechnology Morgans, Australia
What’s new in 2014? Conference Day One
Dr Sofie Qiao Managing Director, WuXi Venture Fund WuXi AppTec, China
Introduction
AU$400
3-4 December 2014; Crown Conference Centre, Melbourne
Ben Borson Founder and President Borson Law Group, United States
Register by
Overview
AUSTRALIA
Co-organisers:
Delegate profile of 2013 event: by Company Type:
Why attend Australia Biotech Invest 2014?
5.0% 16.9% 3.3% 2.0% 7.0% 0.3% 42.9% 4.0% 1.0% 8.0% 1.3% 0.7% 7.0% 0.7%
“After a good experience in Hong Kong at Asia Biotech Invest we went to Australia Biotech Invest hoping for the same. We were wrong! It far exceeded expectations and we are following up with four potential investor groups - keep it up Ausbiotech!” Brad Walsh, CEO, Minomic International “Having all the attendees in a closed location meant it was easy to locate and converse with investors and fellow Biotech colleagues. The booth concept was a winner.” Nick Ede, Executive Director, Imugene
• Family offices
Eric N. Shiozaki, Director, Apposite Capital
Who Should Attend? • Institutional investors • Private equity investors • Venture capitalists
• Fund managers
4.6% 8.6% 20.5% 5.0% 15.2% 4.0% 3.0% 4.3% 34.8%
Conference Day Two
• Angel investors
“The Ausbiotech Biotech Invest 2013 and Ausbiotech 2013 conferences were informative, dynamic and productive. The panel format and discussion topics at Ausbiotech Biotech Invest 2013 were particularly constructive. They facilitated engaging dialogue during which regional and industry-specific issues were openly discussed. As an investor, I was particularly impressed with the range of participating stakeholders from the investment and start-up biotech communities. Ausbiotech 2013 provided a great platform for all industry stakeholders, ranging from entrepreneurs to large pharma management, and local academics to international investors.”
Conference Day One
by Job Function:
Analyst BD / Marketing C-Level Consultant Investment Management Media Others Regulatory Senior Management
Introduction
Academic / Association Biotech CMO / CRO Communication Strategies Government Hospital Investor Media Others Pharma Research Institute Science Park Services Stock Exchange
In 2014, the program will feature at least 40 biotech company presentations, including 5 - 10 international companies. The program will also feature a mix of expert panellists, and keynote speakers from across the world.
Attendance at the event allows delegates, investors and companies the opportunity to use the biopartnering system. This provides individuals and companies the chance to prearrange one-on-one meetings to take place during the event. In previous years, this system has been responsible for many fruitful discussions, which have lead to deals taking place between investors and biotech companies.
What delegates have said about the 2013 event:
Overview
Australia Biotech Invest, jointly organised by AusBiotech and Beacon Events, brings together life science investors with biotech innovators from Australia, and worldwide. The event series, run twice yearly in both Melbourne, Australia, and Hong Kong, provides the perfect opportunity for biotech companies to present their pipeline to a room full of bone fide investors.
by Countries / Regions:
• Major pharmaceutical companies • Brokerage firms • Stock exchanges • Consultants
Australia / New Zealnd Asia Europe North America
88.4% 5.3% 2.6% 3.6%
2013 Attended Investors
• Investment banks
• Analysts • Law firms Plus: Biotech companies looking for funding or partners For presenting, sponsorship and exhibition opportunities, please contact (Australia/New Zealand) Amelia Lundstrom:
[email protected] | (Rest of World) King Tai:
[email protected] or Shahid Shaikh:
[email protected]
Registration
• CMOs and CROs
09:15
WELCOME & OFFICIAL OPENING Glenn Cross, Chief Operating Officer, AusBiotech
09:25
Conference chairman’s opening remarks and business card exchange Joshua Funder, Partner, GBS Venture Partners
09:30
KEYNOTE: Global investment trends and opportunities • Biotech investment trends, opportunities and business models for future growth
09:45
KEYNOTE: Overview of biotech investment in Asia • Investment trends and opportunities in biotech and life sciences in Asia
10:00
PANEL: International investor panel: what’s hot in life sciences • Long term investment outlook for biotech from investors’ perspective • The future of biotech: key challenges and opportunities • What’s hot in life sciences and where is the money being invested Moderator: Joshua Funder, Partner, GBS Venture Partners Panellists: Dr Sofie Qiao, Managing Director, WuXi Venture Fund, WuXi AppTec, China
11:30
Morning tea, networking with exhibitors & investors and 1-on-1 meetings
12:00
PANEL: Assessing Biotech drivers and performance in Australia and New Zealand: What can Biotechs do to better access capital from these lucrative capital markets? • Assessing stock performance across key exchanges • Spotlight on recent listings and outlook for IPOs • Which stocks are on the analysts’ watch list, and why? Moderator George Syrmalis, CEO & Executive Chair, IQX Investment Labs Panellists: Scott Power, Senior Analyst Healthcare & Biotechnology, Morgans, Australia James Posnett, Manager Listings Business Development, ASX Steven Yatomi-Clarke, Director, Corporate Finance, Patersons Securities Dr Graeme Wald, Investment Director, Bioscience Managers Biotech Company Spotlight Presentations
13:45
Lunch and networking with exhibitors & investors and 1-on-1 meetings
Biotech Company Spotlight Presentations
16:00
Afternoon tea and networking with exhibitors & investors and 1-on-1 meetings
16:30
PANEL: Growing biotech business through international partnering & licensing • Global trends in international partnering and licensing: examining successful partnership models • What do big pharma look for in a biotech partner? • Partnerships key challenges and opportunities Moderator: Joshua Funder, Partner, GBS Venture Partners Panellists: Peter Soelberg, Managing Director – Australasia, Novo Nordisk Pharmaceuticals Jason Coloma, Global Head of Venture & Innovation, Roche Yinxiang Wang, CEO and Chief Scientistic Officer, Betta Pharmaceuticals
17:00
Networking Reception Sponsored by
Supporting Associations: Biotechnologie-Industrie-Organisation Deutschland e. V.
Supporting Organisations:
To register, www.AusBiotechInvest.com/registration or contact Beacon Events at +852 2219 0111 or email to
[email protected]
Registration
12:45
15:00
2013 Attended Investors
Biotech Company Spotlight Presentations
PANEL: Maximising your after tax return on investment in Australia – strategies and opportunities • Tax and financial structures for start-ups in order to leverage the R&D incentive • Current “state of play” of the R&D tax incentives and grants available • Understanding the Australian Manufacturing Incentive scheme and how can Biotechs enhance their access to these financial grants? Moderator: Joshua Funder, Partner, GBS Venture Partners Panellists: David Wilson, General Manager, R&D Tax Incentive, AusIndustry – Entrepreneur Development
Conference Day Two
10:30
14:30
Conference Day One
Registration and morning coffee
Introduction
08:30
Overview
DAY ONE – Wednesday 3 December 2014
Conference chairman’s opening remarks and day one recap Matt McNamara, Chief Investment Officer, BioScience Managers
09:10
KEYNOTE: Why resource sector investors look at biotech Brian Leedman, Branch Chair, AusBiotech
09:30
PANEL: Resource investors • The link between the risk and return of small mining companies and companies in the biotech sector • Shift in investor capital from small resources to biotech Moderator: Glenn Cross, Chief Operating Officer, AusBiotech Panellists: Brian Leedman, Branch Chair, AusBiotech Richard Hopkins, Chief Executive Officer, Phylogica Anton Uvarov, PhD, Healthcare Analyst, Forrest Capital Mike Munro, Investment Broker, Hartleys
10:00
Biotech Company Spotlight Presentations
11:00
Morning tea, networking with exhibitors & investors and 1-on-1 meetings
11:30
KEYNOTE: An update on investment opportunities in Victoria • Views on the essential elements that make Melbourne a place to invest for biotech Cameron Boardman, Executive Director – Innovation, Technology & Industry Programs, Department of State Development, Business & Innovation
12:00
Biotech Company Spotlight Presentations
13:00
Lunch and networking with exhibitors & investors and 1-on-1 meetings Biotech Company Spotlight Presentations
15:00
KEYNOTE: The rapidly evolving healthcare investment landscape in Greater China • Current developments in China’s biotech and medtech sector • Outlook for China’s healthcare market for 2015 and beyond and expected impact on investment opportunities in the sector • The state of VC investment Wen Cao, Principal of Shanghai Office, NTD Patent & Trademark Agency, China
15:45
Biotech Company Spotlight Presentations
16:35
CLOSING PANEL Key challenges and investment opportunities for biotech in coming 5 years • Key challenges and opportunities for biotech investment and innovation going forward and will biotech live up to its potential? Moderator: Matt McNamara, Chief Investment Officer, BioScience Managers
17:00
Chairman’s closing remarks
Exhibition Floor plan:
Conference Hall
Registration
2013 Attended Investors
14:00
PANEL: Building win-win partnerships in China • What do investors in Asia look for when investing into biotech companies? What types of companies at what stage are most favoured? • How can biotech companies best position themselves to attract capital and/or set up partnerships in Asia? • Accessing funding and grants and collaborating across borders Moderator: Matt McNamara, Chief Investment Officer, BioScience Managers Panellists: Dr Samantha Du, Chairman & CEO, Zai Laboratory; Venture Partner, Sequoia Capital, China Barry Palte, Executive Deputy Chairman, Bluemount Capital, Australia Dr Richard M Soll, Senior Vice President, International Discovery Service Unit, WuXi AppTec, China Dr Dan Zhang, CEO, Fountain Medical, China Benjamin Borson, Founder and President, Borson Law Group, United States
Conference Day Two
09:00
15:15
Conference Day One
Registration and morning coffee
Introduction
08:30
Overview
DAY TWO – Thursday 4 December 2014
Media Partners:
Registration
For presenting, sponsorship and exhibition opportunities, please contact (Australia/New Zealand) Amelia Lundstrom:
[email protected] | (Rest of World) King Tai:
[email protected] or Shahid Shaikh:
[email protected]
Sponsoring or exhibiting at the Biotech Invest conferences provides a unique opportunity to promote your company to the assembled audience of investors and life science experts. We offer tailored sponsorship opportunities designed to meet your specific marketing needs.
Take an exhibition booth and one of the limited high-profile company spotlight slots on the agenda to showcase your projects and investment opportunities to the investors and potential JV partners at the event.
Pharma companies:
Service providers, law firms and industry consultants:
Consider taking up the Knowledge Partner package to showcase your thought leadership to the biotech companies, big pharma representatives and life science investors attending the event.
Australia / New Zealand Amelia Lundstrom T: +61 3 9828 1435 E:
[email protected]
• RBS Morgans
• Afandin
• Goldman Sachs
• Scientia Capital
• AFG Venture Group
• Grannus Securities
• Alex Cowie
• Hawkesbury Partners
• Self-Managed Super Funds Professionals Association of Australia
• Anchor Advisory
• Hirst Shabian & Hirst Advisory & Investment Services
• Apposite Capital • Aqua Capital • Atwill Consulting • Baillieu Holst • Baker Young Stockbrokers • Bartov Enterprises • Beconwood Securities • Bergen Capital • Bio Innovation • BioPacificVentures • Bioscience Managers • Bluehawk Capital • Brandon Capital Partners • Calpain Therapeutics • Canterbury Funds Management • China BlueSky Ventures • CIMB Securities • Cooper Investors • CSIRO - Materials Science & Engineering • Cure Kids Ventures • Dazane • Dewver • Duce Investments • E.L. & C. Baillieu Stockbroking • EcoR1 Capital Fund • Edison Investment Research • EWave • Fairview Equity Partners • Farego Enterprise • Fitzroy Capital • Fortrend Securities
• Somerset Capital
• IFM Investors
• Starfish Ventures
• Innovation Capital
• Strategic Management
• IQX Ltd Janssen-Cilag
• Szabo Trading
• JDG
• Talu Ventures
• Jevons Global
• Terrain Capital
• JM Financial Group
• Thomas Hannaford
• Kamara Poulos Group - KPG
• Trans Tasman Commercialisation Fund - TTCF
• Kinetic Investment Partners
• Uniseed Ventures
• Lion Capital
• VAGO- Victorian Auditor-Generals Office
• Lodge Partners
• Veritas Securities
• Macquarie Capital
• Walravens Family Super fund
• Macquarie Private Wealth • Magna Group Capital Management • MedImmune Ventures • Merck Sharp & Dohme • Milford Asset Management
Job Function - Investor:
• Morgans Financial • Newcontent • Obi-Wan Investments • OrbiMed • Oxford Capital • PAC Partners • Patersons Securities • Peloton Capital • pharmaBank • PharmaVentures • PhillipCapital • Platinum Road • Prime Value Asset Management • Private Investor • Private Portfolio Managers
Analyst BD / Marketing C-Level Investment Management Senior Management
For presenting, sponsorship and exhibition opportunities, please contact (Australia/New Zealand) Amelia Lundstrom:
[email protected] | (Rest of World) King Tai:
[email protected] or Shahid Shaikh:
[email protected]
10.9% 1.6% 9.3% 34.1% 44.2%
Registration
• Fenex Capital Management
• Shire Australia
2013 Attended Investors
Rest of the World King Tai Shahid Shaikh T: +852 2531 6125 T: +852 2531 6218 E:
[email protected] E:
[email protected]
• QIC
• GE
Conference Day Two
Contact us to find out how you can participate in the Australia Biotech Invest 2014.
• GBS Venture Partners
• Acuity Capital
Conference Day One
Take up one of the limited high-profile company presentation slots on the agenda to highlight your licensing and partnering opportunities to the biotech entrepreneurs attending the event.
• 90 West Asset Management
Introduction
Biotech companies:
Investors attending the 2013 event included:
Overview
Why Sponsor Biotech Invest?
2014
Click here to submit form via email
Phone + 852 2219 0111
Email
[email protected]
Fax +852 2219 0112
Mail: Beacon Events Limited 20/F Siu On Centre, 188 Lockhart Road, Wanchai, Hong Kong
3-4 December 2014 • Crown Conference Centre, Melbourne
Register & pay by 26 September 2014 Standard rate
Register & pay by 31 October 2014
Venue Information
Thereafter
Fee
GST
Total
Fee
GST
Total
Fee
GST
Total
AU$ 1,845 Save AU$400
AU$ 184.5
AU$ 2,029.5
AU$ 2,045 Save AU$200
AU$ 204.5
AU$ 2,249.5
AU$ 2,245
AU$ 224.5
AU$ 2,469.5
Fee
GST
Total
Fee
GST
Total
Fee
GST
Total
Member of supporting associations / organisations*
AU$ 1,345 Save AU$400
AU$ 134.5
AU$ 1,479.5
AU$ 1,545 Save AU$200
AU$ 154.5
AU$ 1,699.5
AU$1,745
AU$ 174.5
AU$ 1,919.5
Non-member
AU$ 1,545 Save AU$400
AU$ 154.5
AU$ 1,699.5
AU$ 1,745 Save AU$200
AU$ 174.5
AU$ 1,919.5
AU$1,945
AU$ 194.5
AU$ 2,139.5
2 day conference Pharma / Biotech Companies / CRO's
Association/Organisation:______________________________________________________________________ Membership Number:______________________________________ Academics / Tech Transfer Officers Full-time staff / student of a nonprofit university, hospital, institute**
Fee
GST
Total
Fee
GST
Total
Fee
GST
Total
AU$1,145
AU$ 114.5
AU$ 1,259.5
AU$1,145
AU$ 114.5
AU$ 1,259.5
AU$1,145
AU$ 114.5
AU$ 1,259.5
Room rate from AUD 280.00 Click here to book a room.
Payment Details (Tick one only) Accept enclosed cheque made payable to Resourceful Australia Pty Ltd Please invoice me
Credit Card Card Type:
Institution:_______________________________________________________________________________ Staff/Student ID Number:______________________________________
Card No.
Conference Day Two
**Delegate must register with an email address that correlates to the institution stated in the Company / Organisation field on the registration form. **Delegate is required to provide a staff or student ID number showing that s/he is at the stated institution to qualify for the Academics rate.
Cardholder’s Name
Your Details (Please use BLOCK LETTERS)
Cardholder’s Signature
(Mr/Mrs/Ms/Miss/Dr) First Name
Last Name
Job Title
Department
Direct Tel
Mobile
Email
Direct Fax
Conference Day One
*Member rates are available to members of a supporting association or organisation. Delegate is required to provide the member registration code and membership details to register with discounts.
Crown Conference Centre, Melbourne, Australia 8 Whiteman Street, Southbank
Introduction
PROMO CODE: BA799MM WEB PROMO CODE: BH793MM TSPH
I will attend at the following rate (please P the appropriate box)
Overview
AUSTRALIA
Yes, I would like to receive information on future events via email. By giving you my email address. I am giving only the organisers the permission to contact me by email.
Your Company Details Company Name Business Nature Address City
Last Name Title Department
No. of Employees State
Postcode
Country
Expiry Date (mm/yy)
Security Code (CVV2):
Payment Amount
Date
2013 Attended Investors
Approving Manager (Mr/Mrs/Ms/Miss/Dr) First Name Job Title
Terms & Conditions*
I acknowledge and accept these terms and conditions
Print Name
Signature
To register, www.AusBiotechInvest.com/registration or contact Beacon Events at +852 2219 0111 or email to
[email protected]
Registration
All discount can only be applied at the time of registration and discount cannot be combined. In the event that more than one discount is applicable, delegates will receive the discount with the highest value. All discounts are subject to approval. Please note the conference fee does not include travel or hotel accommodation costs. 1.Should you be unable to attend, a substitute delegate is always welcome at no extra charge. 2. Alternatively, the organisers can also provide a credit note for attendance one of the future events by Beacon Events within Asia Region (Except Mines and Money Series and IMARC) for cancellations received 14 days prior to the event. Alternatively, a 50% refund will be provided for cancellations received in writing (letter or facsimile) no later than four weeks prior to the event; thereafter we regret no refunds or credit note can be arranged. 3. Beacon Events Ltd reserve the right to alter the programme without notice including the substitution, alternation or cancellation of speakers and / or topics and / or alternation of the dates and / or location of the event. 4. The organisers are not responsible for any loss or damage as a result of a substitution, alternation, postponement or cancellation of any event. ©2014 Beacon Events Ltd. All rights reserved.
